(1) 仿生蛋白类载体的开发
(2) 胞外囊泡药物制剂的成药性研究

科研项目
（1）江苏省自然科学基金青年基金项目，纳米囊泡转运多功能脂蛋白用于调控脑肿瘤代谢微环境和增效肿瘤免疫的研究， 2022-2025，主持
（2）中国药科大学特聘副研究员科研启动经费， 2021-2027， 主持

1.He, H.1; Halseth, T. A.1; Mei, L.; Shen, C.; Liu, L.*; Schwendeman, A.*, Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy. J Control Release 2022, 348, 1016-1027. (IF: 11.467)
2.Ren, L.1; Li, J. 1; Liu, L.1; Wu, W.; Zhao, D.; Zhang, K.; Xin, X.; Yang, L.*; Yin, L.*, Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex. Biomater Sci-Uk 2021, 9 (24), 8259-8269. (IF: 6.843)
3.He, H.1; Hong, K.1; Liu, L.; Schwendeman, A.*, Artificial high-density lipoprotein-mimicking nanotherapeutics for the treatment of cardiovascular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021, 13 (6), e1737. (IF: 9.182)
4.He, H.1; Adili, R.1; Liu, L.1; Hong, K.; Holinstat, M.; Schwendeman, A.*, Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice. Sci Adv 2020, 6 (49). (IF: 14.143)
5.He, H.; Liu, L.; Morin, E. E.; Liu, M.; Schwendeman, A.*, Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures. Acc Chem Res 2019, 52 (9), 2445-2461. (IF: 20.834)
6.Liu, L. 1; Chen, Q.1; Ruan, C.; Chen, X.; He, X.; Zhang, Y.; Zhang, Y.; Lu, Y.; Guo, Q.; Zhou, W.; Li, C.; Sun, T.; Jiang, C.*, Nano-engineered lymphocytes for alleviating suppressive tumor immune microenvironment. Appl Mater Today 2019, 16, 273-279. (IF: 8.352)
7.Chen, Q.; Liu, L.; Lu, Y.; Chen, X.; Zhang, Y.; Zhou, W.; Guo, Q.; Li, C.; Zhang, Y.; Zhang, Y.; Liang, D.; Sun, T.; Jiang, C.*, Tumor Microenvironment-Triggered Aggregated Magnetic Nanoparticles for Reinforced Image-Guided Immunogenic Chemotherapy. Adv Sci (Weinh) 2019, 6 (6), 1802134. (IF: 15.840)
8.Liu, L.; Chen, Q.; Ruan, C.; Chen, X.; Zhang, Y.; He, X.; Zhang, Y.; Lu, Y.; Guo, Q.; Sun, T.; Wang, H.; Jiang, C.*, Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity. Theranostics 2018, 8 (11), 2974-2987. (IF: 8.537)
9.Ruan, C.; Liu, L.; Lu, Y.; Zhang, Y.; He, X.; Chen, X.; Zhang, Y.; Chen, Q.; Guo, Q.; Sun, T.; Jiang, C.*, Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Acta Pharm Sin B 2018, 8 (1), 85-96. (IF: 6.014)
10.Liu, L.; Bi, Y.; Zhou, M.; Chen, X.; He, X.; Zhang, Y.; Sun, T.; Ruan, C.; Chen, Q.; Wang, H.*; Jiang, C.*, Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers. ACS Appl Mater Interfaces 2017, 9 (8), 7424-7435. (IF: 8.079)